|
Title
|
Published
|
Price
|
|
Poland Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
Poland is one of the highest value markets in Central and Eastern Europe (CEE) and as a result is adestination for almost all multinationals operating within the region. Poland’s pharmaceutical market hasshown consistently strong growth
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Thailand Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
In BMI’s Pharmaceutical Environment Ratings (BER) table for Q110, Thailand slipped from ninth totenth position among the 15 key markets surveyed in the Asia Pacific region. Thailand’s growing andageing population represents a substantial commercial opportunity
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Kenya Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
BMI’s proprietary Drug Expenditure Forecast Model reveals that the Kenyan pharmaceutical market willreturn to a double-digit growth rate in 2009 (in local currency terms), after declining to single-digitgrowth the previous year. During 2008, OTC and
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Nigeria Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
The value of Nigeria’s pharmaceutical market in 2008 was NGN80.9bn (US$680mn). We forecast a12.8% year-on-year (y-o-y) growth in local currency during 2009, expecting that the market will grow bya compound annual growth rate (CAGR) of
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Australia Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
Australia’s pharmaceutical market is among the most developed in the Asia-Pacific region. Access tomedication is good across all sections of the population, with per-capita spending calculated at US$352 in2008. While not particularly high by Western
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
Argentina Pharmaceuticals and Healthcare Report Q1 2010
By: Business Monitor International
The value of Argentina’s pharmaceutical market in 2008 was US$3.7bn. BMI’s updated forecasts see themarket reaching a value of US$6.12bn by 2014, representing a compound annual growth rate (CAGR) of12.68% in US dollar terms. With
|
more...
Search inside this report
|
11/10/2009
|
$495.00
|
|
UAE Healthcare Sector Forecast to 2012
By: RNCOS
The UAE has emerged as one the fastest growing healthcare markets in the Middle East. The country’s healthcare sector has grown at double digit rate to keep pace with incessantly rising demand for quality treatment
|
more...
|
11/1/2009
|
$1,000.00
|
|
Romania - Health Care Report
By: TrendsSpotting.com
Romania - Health Care Report offers a comprehensive review of the current state of the Romanian health care system, the pharmaceutical industry and the medical equipment market. It provides a business perspective on private and
|
more...
Search inside this report
|
11/1/2009
|
$250.00
|
|
Lebanon Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
We expect total drug spending in Lebanon to increase from under US$500mn in 2008 to US$605mn in2013, a compound annual growth rate (CAGR) of 3.9% in US dollar terms, with 1.75% of GDP dedicatedto pharmaceutical
|
more...
Search inside this report
|
10/21/2009
|
$495.00
|
|
Belarus Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
A brief recession and the devaluation of the local currency have demonstrated that Belarus has not beenable to escape the global economic crisis, although sheer lack of integration into the global financialsystem has done much
|
more...
Search inside this report
|
10/21/2009
|
$495.00
|
|
Australian Public Sector: Department of Health and Ageing
By: Ovum Plc
The Department of Health and Ageing is responsible for policy in a wide range of areas of health including, medical services, aged care, biosecurity and emergency response. This report profiles the agency and its ICT
|
more...
Search inside this report
|
10/21/2009
|
$895.00
|
|
Bahrain Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
From BHD44mn (US$114mn) in 2008, BMI forecasts that Bahrain’s pharmaceutical market will expandto be worth BHD61mn (US$160mn) in 2018. While the market will remain small in absolute terms, rapidvalue growth, representing a compound annual growth
|
more...
Search inside this report
|
10/15/2009
|
$495.00
|
|
China Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
In BMI’s view, China is arguably the most attractive emerging pharmaceutical market. Though to 2013,we are forecasting a compound annual growth rate (CAGR) of 15.45%. Annual per-capita spending willrise from US$27.60 to US$54.40. Spending as
|
more...
Search inside this report
|
10/15/2009
|
$495.00
|
|
Portugal Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
BMI calculates that pharmaceutical sales in Portugal reached EUR3.61bn (US$5.31bn) in 2008. Wecalculate that the sales of prescription and over-the-counter (OTC) medicines will reach a value ofEUR0.302bn by 2013, equating to a constant annual growth
|
more...
Search inside this report
|
10/15/2009
|
$495.00
|
|
Venezuela Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
BMI calculates that pharmaceutical sales in Venezuela reached VEB7.5bn (US$3.57bn) in 2008. By2013, we forecast the Venezuelan pharmaceutical market will be worth VEB26.0bn, increasing at acompound annual growth rate (CAGR) of 28.23%. BMI notes that
|
more...
Search inside this report
|
10/14/2009
|
$495.00
|
|
South Africa Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
We expect the value of the total pharmaceutical market to increase from US$2.5bn in 2008 to US$4.2bnby 2013, representing a compound annual growth rate (CAGR) of 10.8% in US dollar terms and 8.6% inlocal currency.
|
more...
Search inside this report
|
10/14/2009
|
$495.00
|
|
Lithuania Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
BMI calculates that Lithuania’s pharmaceutical market reached a value of LTL1.70bn (US$0.70bn) in2008. By 2013, we expect the value of the prescription and over-the-counter (OTC) markets to reach avalue of LTL2.13bn, equating to a compound
|
more...
Search inside this report
|
10/14/2009
|
$495.00
|
|
United States Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
Despite a downturn in growth rates in the US pharmaceuticals & healthcare markets, the country remainsa core component for any company looking to achieve global success. Healthcare spending in 2008reached US$2.3trn, while sales of pharmaceuticals
|
more...
Search inside this report
|
10/8/2009
|
$495.00
|
|
United Kingdom Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
In BMI’s Business Environment Ratings (BER) for Q409, the UK improved its position by one place,and is now ranked 5th of the 9 Western European markets surveyed. However, while the UK is one of themost
|
more...
Search inside this report
|
10/8/2009
|
$495.00
|
|
Spain Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
In BMI’s Business Environment Ratings for Q409, Spain remains placed fourth out of the nine WesternEuropean Markets surveyed. Spain’s large and generously subsidised drug market, low genericpenetration, ageing population and stable economic and political system
|
more...
Search inside this report
|
10/8/2009
|
$495.00
|
|
Peru Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
BMI calculates that pharmaceutical sales in Peru reached PEN2.58bn (US$0.88bn) in 2008. Thisrepresents impressive growth of 8.5% in local currency terms between 2007 and 2008. However, BMI’sforecast for 2009 is more conservative and we calculate
|
more...
Search inside this report
|
10/8/2009
|
$495.00
|
|
Russia Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
This quarter BMI introduces 10-year forecasts for the Russian pharmaceutical markets, providing anopportunity to look beyond the current financial crisis and assess the growth potential for the largest andmost populous pharmaceutical market in Central and
|
more...
Search inside this report
|
10/8/2009
|
$495.00
|
|
Estonia Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
Estonia’s pharmaceutical market is unlikely to be a prime target for multinational drugmakers expandinginto foreign countries. Despite rapid economic growth in recent years, which has translated into strongheadline growth for pharmaceutical expenditure, the country’s population
|
more...
Search inside this report
|
10/7/2009
|
$495.00
|
|
India Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
In the Q409 update of BMI’s India Pharmaceuticals & Healthcare report, we have introduced our 10-yearDrug Expenditure Forecast Model. The country’s US$14.23bn pharmaceutical market is forecast to reacha value of US$44.99bn by 2018, representing a
|
more...
Search inside this report
|
10/7/2009
|
$495.00
|
|
Czech Republic Pharmaceuticals and Healthcare Report Q4 2009
By: Business Monitor International
The Czech Republic has one of the most developed and technologically advanced pharmaceutical marketsin Central & Eastern Europe (CEE). Despite the impact of the economic downturn, BMI believes thatCzech medicine sales growth will remain healthy,
|
more...
Search inside this report
|
10/7/2009
|
$495.00
|
|
Title
|
Published
|
Price
|
(0 items)
